Related Experiment Video
Updated: Jul 10, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Chiral salicyl diamines: potent anticancer molecules
Jian Gao1, Ya-Guang Liu, Yaqing Zhou
1Department of Chemistry, Texas A&M University, College Station, TX 77843-3255, USA. gaojiantamu@yahoo.com
Abstract:
A set of 12 enantiomeric diamine-based small molecules was synthesized and screened for anticancer activity against five human cancer cell lines: NCI-H460, A549, MCF-7, SK-BR-3, and T-47D. The salicyl diamino compounds (1-6) were found to induce inhibition of the growth of cancer cells at submicromolar concentrations. The lead compound, N,N'-bis-salicyl-(1R,2R)-diaminocyclohexane (1) displayed single-reagent anticancer activity with an IC(50) value equal to or less than 2.0 microM in H460 and A-549 cancer cells. SRB and colony formation assays indicated that compound 1 shows greater cytotoxic activity toward MCF-7 cells than MCF-10A cells. Real-time RT-PCR analysis demonstrated that compound 1, is an extremely efficient regulator of antiapoptotic genes, Bcl-xL, Bcl-2, and the cell cycle related gene, cyclin D1. This study provides a new insight into the development of novel small molecules in the treatment of human breast cancers.
Insights
Researchers developed novel small molecules for cancer treatment. The lead compound, N,N'-bis-salicyl-(1R,2R)-diaminocyclohexane (1), effectively inhibited cancer cell growth, particularly in breast cancer cells, by regulating key genes.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Oncology
Background:
- Small molecules are crucial in cancer therapy.
- Developing novel anticancer agents with targeted mechanisms is essential.
- Diamine-based compounds offer a promising scaffold for drug discovery.
Purpose of the Study:
- To synthesize and evaluate the anticancer potential of enantiomeric diamine-based small molecules.
- To identify lead compounds with potent activity against various human cancer cell lines.
- To elucidate the molecular mechanisms underlying the anticancer effects of the lead compound.
Main Methods:
- Synthesis of 12 enantiomeric diamine-based small molecules.
- Anticancer activity screening against NCI-H460, A549, MCF-7, SK-BR-3, and T-47D cell lines.
- Cytotoxicity assessment using SRB and colony formation assays.
- Gene expression analysis (Bcl-xL, Bcl-2, cyclin D1) using real-time RT-PCR.
Main Results:
- Salicyl diamino compounds (1-6) inhibited cancer cell growth at submicromolar concentrations.
- Lead compound 1 exhibited potent anticancer activity (IC50 ≤ 2.0 μM) in H460 and A-549 cells.
- Compound 1 demonstrated selective cytotoxicity towards MCF-7 (breast cancer) cells over MCF-10A (normal breast cells).
- Compound 1 efficiently regulated antiapoptotic genes (Bcl-xL, Bcl-2) and cell cycle gene (cyclin D1).
Conclusions:
- N,N -bis-salicyl-(1R,2R)-diaminocyclohexane (1) is a promising lead compound for anticancer drug development.
- Compound 1's mechanism involves the regulation of apoptosis and cell cycle pathways.
- This study offers insights for developing novel small molecules targeting human breast cancers.
Related Concept Videos
Chirality in Nature
Molecules with Multiple Chiral Centers
Chirality at Nitrogen, Phosphorus, and Sulfur
A consequence of chirality is the need for enantiomeric resolution. While this is theoretically possible for all...
Chirality
Chiral objects exhibit a sense of handedness when they interact with another chiral object. For example, our left foot can only fit in the left shoe and not in the right shoe. Achiral objects — objects that have...
Prochirality
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists